Monkeypox during Covid-19 era in Africa: Current challenges and recommendations

dc.contributor.authorOkonji, Osaretin Christabel
dc.contributor.authorOkonji, Emeka Francis
dc.date.accessioned2022-09-06T08:40:12Z
dc.date.available2022-09-06T08:40:12Z
dc.date.issued2022
dc.description.abstractIn May 2022, monkeypox virus (MPXV) outbreak was confirmed amid the coronavirus disease 2019 (COVID-19) pandemic in many parts of the world including Africa. This is the largest outbreak since monkeypox (MPX) was first detected in humans in 1970. The MPX outbreak in Africa is an added burden to the fragile healthcare systems that are already overburdened with several reoccurring epidemics. Although several efforts are in place to effectively contained the outbreak. Several measures such as improved surveillance and diagnostic are necessary to contain the spread of the disease in Africa. This commentary highlights the challenges with the MPX outbreak in Africa and discusses the measures that can be taken to limit the spread of the disease, particularly in high-risk countries.en_US
dc.identifier.citationOkonji, O. C., & Okonji, E. F. (2022). Monkeypox during Covid-19 era in Africa: Current challenges and recommendations. Annals of Medicine and Surgery, 81,104381. https://doi.org/10.1016/j.amsu.2022.104381en_US
dc.identifier.issn2049-0801
dc.identifier.urihttps://doi.org/10.1016/j.amsu.2022.104381
dc.identifier.urihttp://hdl.handle.net/10566/7806
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectCovid-19en_US
dc.subjectMonkeypoxen_US
dc.subjectPublic healthen_US
dc.subjectAfricaen_US
dc.subjectDiseaseen_US
dc.titleMonkeypox during Covid-19 era in Africa: Current challenges and recommendationsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
okonji_monkeypox during covid-19 era_2022.pdf
Size:
268.23 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: